Statistical tests for clonality.
Cancer investigators frequently conduct studies to examine tumor samples from pairs of apparently independent primary tumors with a view to determine whether they share a "clonal" origin. The genetic fingerprints of the tumors are compared using a panel of markers, often representing loss of heterozygosity (LOH) at distinct genetic loci. In this article we evaluate candidate significance tests for this purpose. The relevant information is derived from the observed correlation of the tumors with respect to the occurrence of LOH at individual loci, a phenomenon that can be evaluated using Fisher's exact test. Information is also available from the extent to which losses at the same locus occur on the same parental allele. Data from these combined sources of information can be evaluated using a simple adaptation of Fisher's exact test. The test statistic is the total number of loci at which concordant mutations occur on the same parental allele, with higher values providing more evidence in favor of a clonal origin for the two tumors. The test is shown to have high power for detecting clonality for plausible models of the alternative (clonal) hypothesis, and for reasonable numbers of informative loci, preferably located on distinct chromosomal arms. The method is illustrated using studies to identify clonality in contralateral breast cancer. Interpretation of the results of these tests requires caution due to simplifying assumptions regarding the possible variability in mutation probabilities between loci, and possible imbalances in the mutation probabilities between parental alleles. Nonetheless, we conclude that the method represents a simple, powerful strategy for distinguishing independent tumors from those of clonal origin.
Begg
Colin B
CB
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 E. 63rd Street, Room 303, New York, New York 10021, USA. beggc@mskcc.org
Eng
Kevin H
KH
Hummer
Amanda J
AJ
D001699:Biometry / Q000379:methods*; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics; D005260:Female; D006801:Humans; D019656:Loss of Heterozygosity; D009154:Mutation; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000235:genetics*
Nat Genet. 1998 Oct;20(2):207-11
9771718
Int J Cancer. 2002 Sep 1;101(1):1-6
12209580
Int J Cancer. 2002 Aug 10;100(5):557-64
12124805
Genes Chromosomes Cancer. 2005 May;43(1):25-36
15723340
J Natl Cancer Inst. 2004 Oct 6;96(19):1441-6
15467033
Mod Pathol. 2004 May;17(5):597-602
15017434
Am J Clin Pathol. 2005 May;123(5):679-89
15981807
Breast Cancer Res Treat. 2000 Dec;64(3):241-51
11200774
Pathol Res Pract. 2004;200(10):735-41
15648612
J Clin Oncol. 2004 May 15;22(10):1830-8
15143075
Biostatistics. 2002 Dec;3(4):445-57
12933591
Am J Pathol. 2003 Apr;162(4):1095-101
12651602
Biostatistics. 2004 Oct;5(4):557-72
15475419
Cancer Res. 1997 Apr 15;57(8):1597-604
9108466
Surgery. 1994 Apr;115(4):458-62
7909387
Crit Rev Oral Biol Med. 2003;14(5):363-9
14530304
J Natl Cancer Inst. 2006 Jan 4;98(1):15-25
16391368